Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process...
Keep Reading →
August 29 - News, Stock Analysis
Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in...
Keep Reading →
August 1 - Earnings Report, News, Tech
The U.S stock markets are trading up on Monday even as oil has tumbled, thanks to strong financial results and M&A news. Among the stocks on the move today are LendingClub Corp...
Keep Reading →
July 18 - Market Movers, News
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be.
Keep Reading →
June 13 - Hedge Fund Analysis, Hedge Funds
GlaxoSmithKline plc (ADR) (NYSE:GSK) has come up with a plan that will enable it to file for approval of its triple-combo drug for COPD patients sooner than earlier anticipated...
Keep Reading →
June 9 - News, Stock Analysis
A drug being developed jointly by Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK) met endpoints in a large Phase 3 study that enrolled 1,670 patients...
Keep Reading →
June 8 - News, Stock Analysis
GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.
Keep Reading →
June 8 - News, Stock Analysis
Deerfield Management, a healthcare-focused fund managed by James E.
Keep Reading →
December 11 - Hedge Funds, News
Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.
Keep Reading →
November 27 - Hedge Funds, News
When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.
Keep Reading →
June 27 - Lists
Hedge funds have started submitting their 13F filings with the SEC, offering other investors a chance to look at their equity holdings as of the end of the first quarter.
Keep Reading →
April 24 - Hedge Funds, News
GlaxoSmithKline plc (ADR) (NYSE:GSK) remains committed to eradicating the deadly virus which has already claimed more than 2,000 lives in Western Africa and is considered as the...
Keep Reading →
September 8 - News
Companies around the world, who do business in China were keeping a close watch on the trial of the British company investigator, Peter Humphrey, and his American wife and...
Keep Reading →
August 10 - News
In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr.
Keep Reading →
July 18 - Earnings Report, News
Rio Tinto plc (ADR) (NYSE:RIO), the world’s second-biggest mining company, is now seeing iron ore trading close to $100 per metric ton.
Keep Reading →
July 17 - News
Warren Buffett’s Berkshire Hathaway, in its latest 13F, revealed its equity portfolio held at the end of the fourth quarter of 2013.
Keep Reading →
February 14 - Hedge Funds, News
Relvar Ellipta: Over the past few days, research-based pharmaceutical GlaxoSmithKline plc (ADR) (NYSE:GSK) and biopharmaceutical company Theravance Inc (NASDAQ:THRX)’s Relvar...
Keep Reading →
September 23 - News
To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.
Keep Reading →
September 23 - News
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Keep Reading →
September 23 - News
There is perhaps nothing scarier than a cancer diagnosis.
Keep Reading →
September 17 - News
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Keep Reading →
September 17 - News
There's no question that America is addicted to caffeine and sugar.
Keep Reading →
September 17 - News
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive pulmonary disease...
Keep Reading →
September 16 - News
There are plenty of biotech companies that put all of their eggs in one basket these days.
Keep Reading →
September 16 - News
Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.
Keep Reading →
September 16 - News
In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they're hot like summer, sometimes they're dormant and cold like winter.
Keep Reading →
September 16 - News
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
September 15 - News
There hasn't been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before the Food and Drug Administration...
Keep Reading →
September 12 - News
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
September 12 - News
It hasn't been a fun month to be an investor in clinical-stage biotech ChemoCentryx Inc (NASDAQ:CCXI).
Keep Reading →
September 11 - News
China has loomed large in health care headlines recently, due to the GlaxoSmithKline plc (ADR) (NYSE:GSK) scandal that erupted in July.
Keep Reading →
September 11 - News
I know it's like comparing apples and oranges, but humor me for a moment.
Keep Reading →
September 11 - News
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S.
Keep Reading →
September 11 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
September 10 - News
China's not losing importance in the eyes of investors, despite the world's second-largest economy's slump this year.
Keep Reading →
September 10 - News
Emerging-market stocks have been butchered over the past few months amid fears that the Federal Reserve will begin winding down its bond-buying program.
Keep Reading →
September 10 - News
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for a treat this week with...
Keep Reading →
September 9 - News
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
September 9 - News
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Keep Reading →
September 6 - News
Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought to market.
Keep Reading →
September 4 - News
In the financial world, there are many methods market participants can use to track the equity markets.
Keep Reading →
September 3 - News
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Keep Reading →
August 30 - News
Drugs fail their clinical trials for all kinds of reasons. Sometimes, it's related to efficacy; sometimes, it's safety related.
Keep Reading →
August 30 - News
In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it.
Keep Reading →
August 29 - News
A small section of the total Crohn's Disease) patient population is resistant to standard treatment options.
Keep Reading →
August 29 - News
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Keep Reading →
August 29 - News
ViiV Healthcare -- a joint venture by Pfizer Inc.
Keep Reading →
August 28 - News
At the same time, the pharmaceutical industry isn't without its share of risks.
Keep Reading →
August 28 - News
Shares of Perrigo Company (NYSE:PRGO), one of the world's largest health care suppliers, slid with the broader market on Aug.
Keep Reading →
August 27 - News
